Arrayit Corporation (OTC.BB: ARYC), a leading manufacturer of products and services for disease prevention, treatment and cure, announced today that its microarray-based diagnostic test, patented under the trade name Variation Identification Platform (VIP), is ready for manufacture and distribution. A breakthrough screening test using VIP will allow clinicians and researchers to test and detect the […]
Oncology Test Further Highlights Broad Market Applicability of GeneXpert System SUNNYVALE, Calif., June 17 — Cepheid (Nasdaq: CPHD – News) today announced the release of its improved Xpert® BCR-ABL Monitor test to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. With improved time-to-results, the test now […]
Transaction Allows QIAGEN to Increase Focus On Personalized Medicine Applications of HLA Testing Products VENLO, The Netherlands, June 16, 2009 — QIAGEN N.V. (Nasdaq:QGEN – News; Frankfurt:QIA – News) today announced that it has signed an agreement to transfer distribution rights on July 1, 2009 for the Olerup SSP(r) product line and the related assets […]
STOCKHOLM, Sweden–Regulatory News: LinkMed (STO:LMED) today announced the establishment of a new global distribution company, Olerup International AB, as well as the acquisition of the distribution rights for the Olerup SSP® product line from Qiagen GmbH. The transaction includes the takeover of Qiagen’s Austrian sales company. From July 1, 2009, the new company, Olerup International […]
Hong Kong, June 11, 2009 – (ACN Newswire) – The Board of Mingyuan Medicare Development Company Limited (“Mingyuan Medicare” or the “Company”, Stock code: 0233) is pleased to announce today that the Company had entered into a milestone co-operation agreement (the “Co-operation Agreement”) with Chinese National Human Genome Centre in Shanghai (“CHGC”) and Shanghai Biochip […]
MADISON, Wis.–Gentel Biosciences, an acknowledged leader in protein microarray technology, announced it has been invited to join a collaborative Clinical Research and Development consortium using novel technologies developed by the company to gain insight into major diseases of pregnancy. Gentel will participate in the development, validation and deliver a quantitative multiplex protein assay to the […]
CAMBRIDGE, Mass.–Knome, a recognized pioneer in the personal genomics field, today announced that it will collaborate with SeqWright, a world-leader in custom genomic and molecular biology services, to offer its personal genome sequencing and analysis services through a CLIA-certified laboratory. CLIA, or Clinical Laboratory Improvement Amendments, are quality standards developed by the federal government for […]
New Capabilities Will Further Extend GeneXpert System Technology Advantages SUNNYVALE, Calif., June 10 — Cepheid (Nasdaq: CPHD – News) today announced that it has received a notice of grant award from the National Institute of Allergy and Infectious Diseases to develop new ten-color detection technology for use in its GeneXpert® System. The $7.5 million grant […]
CE IVD Marked Tests Can Quickly and Accurately Detect Up to 39 and 71 Cystic Fibrosis Gene Mutations AUSTIN, Texas–Luminex Corporation (NASDAQ: LMNX – News), the worldwide leader in multiplexed solutions, today announced that it has launched two new cystic fibrosis (CF) tests in Europe, the xTAG® Cystic Fibrosis 39 Kit v2 and xTAG® Cystic […]
Lab Will Support MammaPLUS Launch Set for Fall 2009 MOUNTAIN VIEW, Calif.–Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that it has opened the Perlegen Clinical Laboratory Services facility at its Mountain View location, following a successful inspection for CLIA (Clinical Laboratory Improvement Amendments) licensure […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
